Ali Dirani

Lachance A, You E, Garneau J, Bourgault S, Caissie M, Tourville É, Dirani A

Revision Surgery for Idiopathic Macular Hole after Failed Primary Vitrectomy.

J Ophthalmol, 2021 , 2021, ISSN: 2090-004X.

Résumé | Liens:

Houle O, You E, Hébert M, Jin S, Qi SR, Dirani A

Retinal Displacement: Providing New Insights for Retinal Detachment Surgery.

J Ophthalmol, 2021 , 2021.

Résumé | Liens:

Hébert M, You E, Hammamji K, Bourgault S, Caissie M, Tourville É, Dirani A

Impact of patient face mask use on endophthalmitis after intravitreal anti-VEGF injections.

Can J Ophthalmol, 2021.

Résumé | Liens:

Rozon JP, Lavertu G, Hébert M, You E, Bourgault S, Caissie M, Tourville E, Dirani A

Clinical Characteristics and Prognostic Factors of Posterior Segment Intraocular Foreign Body: Canadian Experience from a Tertiary University Hospital in Quebec.

J Ophthalmol, 2021 , 2021.

Résumé | Liens:

Rozon JP, Hébert M, Bourgault S, Caissie M, Letartre L, Tourville E, Dirani A

Fear Associated with COVID-19 in Patients with Neovascular Age-Related Macular Degeneration.

Clin Ophthalmol, 15 , 2021.

Résumé | Liens:

Baya Mdzomba J, Joly S, Rodriguez L, Dirani A, Lassiaz P, Behar-Cohen F, Pernet V

Nogo-A-targeting antibody promotes visual recovery and inhibits neuroinflammation after retinal injury.

Cell Death Dis, 11 (2), 2020.

Résumé | Liens:

Wood EH, Lertjirachai I, Ghiam BK, Koulisis N, Moysidis SN, Dirani A, Drenser KA, Capone Jr, Trese MT

The Natural History of Congenital X-Linked Retinoschisis and Conversion between Phenotypes over Time.

Ophthalmol Retina, 3 (1), 2019.

Résumé | Liens:

Mantel I, Dirani A, Zola M, Parvin P, De Massougnes S, Bergin C

MACULAR ATROPHY INCIDENCE IN ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR-TREATED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Risk Factor Evaluation for Individualized Treatment Need of Ranibizumab or Aflibercept According to an Observe-and-Plan Regimen.

Retina, 39 (5), 2019.

Résumé | Liens:

Mantel I, Zola M, De Massougnes S, Dirani A, Bergin C

Factors influencing macular atrophy growth rates in neovascular age-related macular degeneration treated with ranibizumab or aflibercept according to an observe-and-plan regimen.

Br J Ophthalmol, 103 (7), 2019.

Résumé | Liens:

Kowalczuk L, Matet A, Dor M, Bararpour N, Daruich A, Dirani A, Behar-Cohen F, Thomas A, Turck N

Proteome and Metabolome of Subretinal Fluid in Central Serous Chorioretinopathy and Rhegmatogenous Retinal Detachment: A Pilot Case Study.

Transl Vis Sci Technol, 7 (1), 2018.

Résumé | Liens: